:

Silambarasan Tamil Selvan1, Mukesh Kumar Dharmalingam Jothinathan1

  • 1Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, IND.

Cureus
|April 29, 2024
PubMed
概括

黄化合物显示出作为抗冠状病毒 (CoV) 抗病毒剂的潜力. 计算研究确定了hesperidin和narirutin作为有希望的候选人,针对主要蛋白酶 (Mpro) 进行进一步的实验验证.